{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:14:18Z","timestamp":1794492858476,"version":"4.9.1"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer, one of the leading illnesses, accounts for about 10\u00a0million deaths worldwide. The treatment of cancer includes surgery, chemotherapy, radiation therapy, and drug therapy, along with others, which not only put a tremendous economic effect on patients but also develop drug resistance in patients with time. A significant number of cancer cases can be prevented\/treated by implementing evidence-based preventive strategies. Plant-based drugs have evolved as promising preventive chemo options both in developing and developed nations. The secondary plant metabolites such as alkaloids have proven efficacy and acceptability for cancer treatment. Apropos, this review deals with a spectrum of promising alkaloids such as colchicine, vinblastine, vincristine, vindesine, vinorelbine, and vincamine within different domains of comprehensive information on these molecules such as their medical applications (contemporary\/traditional), mechanism of antitumor action, and potential scale-up biotechnological studies on an in-vitro scale. The comprehensive information provided in the review will be a valuable resource to develop an effective, affordable, and cost effective cancer management program using these alkaloids.<\/jats:p>","DOI":"10.1186\/s12935-022-02624-9","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T06:06:19Z","timestamp":1654149979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":475,"title":["Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine"],"prefix":"10.1186","volume":"22","author":[{"given":"Praveen","family":"Dhyani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Quispe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Bahukhandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Sati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam Chand","family":"Attri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Szopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Oana","family":"Docea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Mardare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Calina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"2624_CR1","doi-asserted-by":"publisher","first-page":"3687700","DOI":"10.1155\/2021\/3687700","volume":"2021","author":"J Sharifi-Rad","year":"2021","unstructured":"Sharifi-Rad J, Quispe C, Patra JK, Singh YD, Panda MK, Das G, Adetunji CO, Michael OS, Sytar O, Polito L, et al. Paclitaxel: application in modern oncology and nanomedicine-based cancer therapy. Oxid Med Cell Longev. 2021;2021:3687700.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"2624_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12935-021-02025-4","volume":"21","author":"J Sharifi-Rad","year":"2021","unstructured":"Sharifi-Rad J, Quispe C, Butnariu M, Rotariu LS, Sytar O, Sestito S, Rapposelli S, Akram M, Iqbal M, Krishna A, et al. Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment. Cancer Cell Int. 2021;21(1):318.","journal-title":"Cancer Cell Int"},{"key":"2624_CR3","doi-asserted-by":"publisher","DOI":"10.5772\/63408","volume-title":"Colorectal cancer and inflammatory bowel disease","author":"P Mitrut","year":"2016","unstructured":"Mitrut P, Docea AO, Kamal AM, Mitrut R, Calina D, Gofita E, Padureanu V, Gruia C, Streba L. Colorectal cancer and inflammatory bowel disease. London: InTech; 2016."},{"issue":"1","key":"2624_CR4","first-page":"175","volume":"56","author":"OM Zlatian","year":"2015","unstructured":"Zlatian OM, Comanescu MV, Rosu AF, Rosu L, Cruce M, Gaman AE, Calina CD, Sfredel V. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer. Rom J Morphol Embryol. 2015;56(1):175\u201381.","journal-title":"Rom J Morphol Embryol"},{"issue":"5","key":"2624_CR5","first-page":"4170","volume":"17","author":"AM Buga","year":"2019","unstructured":"Buga AM, Docea AO, Albu C, Malin RD, Branisteanu DE, Ianosi G, Ianosi SL, Iordache A, Calina D. Molecular and cellular stratagem of brain metastases associated with melanoma. Oncol Lett. 2019;17(5):4170\u20135.","journal-title":"Oncol Lett"},{"issue":"4","key":"2624_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10585-019-09972-3","volume":"36","author":"A Zijlstra","year":"2019","unstructured":"Zijlstra A, Von Lersner A, Yu D, Borrello L, Oudin M, Kang Y, Sahai E, Fingleton B, Stein U, Cox TR, et al. The importance of developing therapies targeting the biological spectrum of metastatic disease. Clin Exp Metastasis. 2019;36(4):305\u20139.","journal-title":"Clin Exp Metastasis"},{"key":"2624_CR7","volume-title":"World cancer report: cancer research for cancer prevention","author":"C Wild","year":"2020","unstructured":"Wild C, Weiderpass E, Stewart BW. World cancer report: cancer research for cancer prevention. Lyon: IARC Press; 2020."},{"issue":"2","key":"2624_CR8","first-page":"189","volume":"65","author":"TA Sani","year":"2017","unstructured":"Sani TA, Mohammadpour E, Mohammadi A, Memariani T, Yazdi MV, Rezaee R, Calina D, Docea AO, Goumenou M, Etemad L, et al. Cytotoxic and apoptogenic properties of dracocephalum kotschyi aerial part different fractions on calu-6 and mehr-80 lung cancer cell lines. Farmacia. 2017;65(2):189\u201399.","journal-title":"Farmacia"},{"key":"2624_CR9","unstructured":"Global, regional, and national burden of colorectal cancer and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022."},{"key":"2624_CR10","doi-asserted-by":"publisher","first-page":"1602437","DOI":"10.1155\/2021\/1602437","volume":"2021","author":"R Hossain","year":"2021","unstructured":"Hossain R, Quispe C, Herrera-Bravo J, Islam MS, Sarkar C, Islam MT, Martorell M, Cruz-Martins N, Al-Harrasi A, Al-Rawahi A, et al. Lasia spinosa: chemical composition and therapeutic potential: a literature-based review. Oxid Med Cell Longev. 2021;2021:1602437.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"2624_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000335590","volume":"58","author":"A Astani","year":"2012","unstructured":"Astani A, Reichling J, Schnitzler P. Melissa officinalis extract inhibits attachment of herpes simplex virus in vitro. Chemotherapy. 2012;58(1):70\u20137.","journal-title":"Chemotherapy"},{"key":"2624_CR12","doi-asserted-by":"publisher","first-page":"6727609","DOI":"10.1155\/2022\/6727609","volume":"2022","author":"J Sharifi-Rad","year":"2022","unstructured":"Sharifi-Rad J, Quispe C, Bouyahya A, El Menyiy N, El Omari N, Shahinozzaman M, Ara Haque Ovey M, Koirala N, Panthi M, Ertani A, et al. Ethnobotany, phytochemistry, biological activities, and health-promoting effects of the genus Bulbophyllum. Evid Based Complement Altern Med. 2022;2022:6727609.","journal-title":"Evid Based Complement Altern Med"},{"key":"2624_CR13","doi-asserted-by":"publisher","first-page":"3268136","DOI":"10.1155\/2021\/3268136","volume":"2021","author":"J Sharifi-Rad","year":"2021","unstructured":"Sharifi-Rad J, Quispe C, Imran M, Rauf A, Nadeem M, Gondal TA, Ahmad B, Atif M, Mubarak MS, Sytar O, et al. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxid Med Cell Longev. 2021;2021:3268136.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"2624_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jdsr.2017.08.003","volume":"54","author":"Y Kato","year":"2018","unstructured":"Kato Y, Maeda T, Suzuki A, Baba Y. Cancer metabolism: new insights into classic characteristics. Jpn Dent Sci Rev. 2018;54(1):8\u201321.","journal-title":"Jpn Dent Sci Rev"},{"key":"2624_CR15","doi-asserted-by":"publisher","first-page":"600139","DOI":"10.3389\/fphar.2021.600139","volume":"12","author":"J Sharifi-Rad","year":"2021","unstructured":"Sharifi-Rad J, Dey A, Koirala N, Shaheen S, El Omari N, Salehi B, Goloshvili T, Cirone Silva NC, Bouyahya A, Vitalini S, et al. Cinnamomum species: bridging phytochemistry knowledge, pharmacological properties and toxicological safety for health benefits. Front Pharmacol. 2021;12:600139\u2013600139.","journal-title":"Front Pharmacol"},{"key":"2624_CR16","doi-asserted-by":"publisher","first-page":"8442734","DOI":"10.1155\/2022\/8442734","volume":"2022","author":"J Sharifi-Rad","year":"2022","unstructured":"Sharifi-Rad J, Quispe C, Kumar M, Akram M, Amin M, Iqbal M, Koirala N, Sytar O, Kregiel D, Nicola S, et al. Hyssopus essential oil: an update of its phytochemistry, biological activities, and safety profile. Oxid Med Cell Longev. 2022;2022:8442734.","journal-title":"Oxid Med Cell Longev"},{"key":"2624_CR17","doi-asserted-by":"publisher","first-page":"6349041","DOI":"10.1155\/2021\/6349041","volume":"2021","author":"MT Islam","year":"2021","unstructured":"Islam MT, Quispe C, El-Kersh DM, Shill MC, Bhardwaj K, Bhardwaj P, Sharifi-Rad J, Martorell M, Hossain R, Al-Harrasi A, et al. A literature-based update on Benincasa hispida (Thunb.) Cogn.: traditional uses, nutraceutical, and phytopharmacological profiles. Oxid Med Cell Longev. 2021;2021:6349041.","journal-title":"Oxid Med Cell Longev"},{"key":"2624_CR18","doi-asserted-by":"publisher","first-page":"9349897","DOI":"10.1155\/2022\/9349897","volume":"2022","author":"R Hossain","year":"2022","unstructured":"Hossain R, Quispe C, Saikat ASM, Jain D, Habib A, Janmeda P, Islam MT, Radha, Da\u015ftan SD, Kumar M, et al. Biosynthesis of secondary metabolites based on the regulation of microRNAs. Biomed Res Int. 2022;2022:9349897.","journal-title":"Biomed Res Int"},{"issue":"1","key":"2624_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/biom9010006","volume":"9","author":"B Salehi","year":"2019","unstructured":"Salehi B, Sestito S, Rapposelli S, Peron G, Calina D, Sharifi-Rad M, Sharopov F, Martins N, Sharifi-Rad J. Epibatidine: a promising natural alkaloid in health. Biomolecules. 2019;9(1):6.","journal-title":"Biomolecules"},{"issue":"16","key":"2624_CR20","first-page":"21","volume":"9","author":"B Salehi","year":"2019","unstructured":"Salehi B, Sharifi-Rad J, Capanoglu E, Adrar N, Catalkaya G, Shaheen S, Jaffer M, Giri L, Suyal R, Jugran AK, et al. Cucurbita plants: from farm to industry. Appl Sci-Basel. 2019;9(16):21.","journal-title":"Appl Sci-Basel"},{"key":"2624_CR21","doi-asserted-by":"publisher","first-page":"5905357","DOI":"10.1155\/2021\/5905357","volume":"2021","author":"D Jain","year":"2021","unstructured":"Jain D, Chaudhary P, Varshney N, Bin Razzak KS, Verma D, Khan Zahra TR, Janmeda P, Sharifi-Rad J, Da\u015ftan SD, Mahmud S, et al. Tobacco smoking and liver cancer risk: potential avenues for carcinogenesis. J Oncol. 2021;2021:5905357.","journal-title":"J Oncol"},{"key":"2624_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13167-020-00210-5","volume":"11","author":"L Koklesova","year":"2020","unstructured":"Koklesova L, Liskova A, Samec M, Qaradakhi T, Zulli A, Smejkal K, Kajo K, Jakubikova J, Behzadi P, Pec M. Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine. EPMA J. 2020;11:261\u201387.","journal-title":"EPMA J"},{"issue":"2","key":"2624_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/molecules22020250","volume":"22","author":"Z Habli","year":"2017","unstructured":"Habli Z, Toumieh G, Fatfat M, Rahal ON, Gali-Muhtasib H. Emerging cytotoxic alkaloids in the battle against cancer: overview of molecular mechanisms. Molecules. 2017;22(2):250.","journal-title":"Molecules"},{"key":"2624_CR24","unstructured":"http:\/\/www.theplantlist.org\/. Accesed 7 Dec 2021."},{"key":"2624_CR25","doi-asserted-by":"publisher","first-page":"112230","DOI":"10.1016\/j.jep.2019.112230","volume":"246","author":"M Heinrich","year":"2020","unstructured":"Heinrich M, Appendino G, Efferth T, F\u00fcrst R, Izzo AA, Kayser O, Pezzuto JM, Viljoen A. Best practice in research\u2014overcoming common challenges in phytopharmacological research. J Ethnopharmacol. 2020;246:112230.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2624_CR26","first-page":"60","volume":"3","author":"A Ansari","year":"2019","unstructured":"Ansari A, Saleem S, Kalam A. Management of Waja\u02b9 al-Rakba (knee Osteoarthritis) by Takm\u012bdH\u0101rRatab (hot and moist fomentation) and Habb-i-S\u016branj\u0101n: a case study. Int J AYUSH Case Rep. 2019;3(1):60\u20138.","journal-title":"Int J AYUSH Case Rep"},{"key":"2624_CR27","unstructured":"Borody TJ, Ramrakha S, Saxon J, Wettstein A. Gastric and colonic formulations and methods for making and using them. Google Patents; 2018."},{"issue":"21","key":"2624_CR28","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.1021\/jf8022723","volume":"56","author":"F Ferreres","year":"2008","unstructured":"Ferreres F, Pereira DM, Valent\u00e3o PC, Andrade PB, Seabra RM, Sottomayor M. New phenolic compounds and antioxidant potential of Catharanthus roseus. J Agric Food Chem. 2008;56(21):9967\u201374.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"2624_CR29","first-page":"1101","volume":"32","author":"HJ Barrales-Cure\u00f1o","year":"2015","unstructured":"Barrales-Cure\u00f1o HJ. Pharmacological applications and in vitro biotechnological production of anticancer alkaloids of Catharanthus roseus. Biotechnol Appl. 2015;32(1):1101\u201310.","journal-title":"Biotechnol Appl"},{"key":"2624_CR30","doi-asserted-by":"publisher","first-page":"114647","DOI":"10.1016\/j.jep.2021.114647","volume":"284","author":"S Kumar","year":"2021","unstructured":"Kumar S, Singh B, Singh R. Catharanthus roseus (L.) G. Don: a review of its ethnobotany, phytochemistry, ethnopharmacology and toxicities. J Ethnopharmacol. 2021;284:114647.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"2624_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/technologies8040080","volume":"8","author":"HNT Pham","year":"2020","unstructured":"Pham HNT, Vuong QV, Bowyer MC, Scarlett CJ. Phytochemicals derived from Catharanthus roseus and their health benefits. Technologies. 2020;8(4):80.","journal-title":"Technologies"},{"issue":"1","key":"2624_CR32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.33545\/2616454X.2020.v4.i1a.115","volume":"4","author":"KM Afsahul","year":"2020","unstructured":"Afsahul KM, Anjum F. Suranjan (Colchicum autumnale L. and merendra persica): great resolvent herbs of Unani system of medicine-a review. Int J Unani Integr Med. 2020;4(1):7\u201311.","journal-title":"Int J Unani Integr Med"},{"issue":"6","key":"2624_CR33","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","volume":"73","author":"E Niel","year":"2006","unstructured":"Niel E, Scherrmann J-M. Colchicine today. Joint Bone Spine. 2006;73(6):672\u20138.","journal-title":"Joint Bone Spine"},{"issue":"5","key":"2624_CR34","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/15563650.2010.495348","volume":"48","author":"Y Finkelstein","year":"2010","unstructured":"Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, Pollak U, Koren G, Bentur Y. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol. 2010;48(5):407\u201314.","journal-title":"Clin Toxicol"},{"issue":"1","key":"2624_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/clpt.2013.148","volume":"95","author":"I Grattagliano","year":"2014","unstructured":"Grattagliano I, Bonfrate L, Ruggiero V, Scaccianoce G, Palasciano G, Portincasa P. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics. Clin Pharmacol Ther. 2014;95(1):89\u201397.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2624_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/ajd.12795","volume":"59","author":"KP Robinson","year":"2018","unstructured":"Robinson KP, Chan JJ. Colchicine in dermatology: a review. Australas J Dermatol. 2018;59(4):278\u201385.","journal-title":"Australas J Dermatol"},{"key":"2624_CR37","unstructured":"Webb LJ. Guide to the medicinal and poisonous plants of Queensland. Bulletin of the Council for Scientific and Industrial Research, Australia. 1948(232)."},{"key":"2624_CR38","first-page":"1","volume":"8","author":"P Bhandari","year":"1959","unstructured":"Bhandari P, Mukerji B. Lochnera rosea Linn Reichb. Gauhati Ayurvedic Coll Mag. 1959;8:1\u20134.","journal-title":"Gauhati Ayurvedic Coll Mag"},{"issue":"7","key":"2624_CR39","first-page":"1152","volume":"37","author":"M Brandao","year":"1985","unstructured":"Brandao M, Botelho M, Krettli E. Antimalarial experimental chemotherapy using natural products. I. A more rational approach? Ci\u00eancia e Cultura. 1985;37(7):1152\u201363.","journal-title":"Ci\u00eancia e Cultura"},{"key":"2624_CR40","unstructured":"Virmani O, Srivastava G, Singh P. Catharanthus roseus\u2014the tropical periwinkle. Indian Drugs. 1978."},{"issue":"12","key":"2624_CR41","first-page":"1","volume":"4","author":"J Aslam","year":"2010","unstructured":"Aslam J, Khan SH, Siddiqui ZH, Fatima Z, Maqsood M, Bhat MA, Nasim SA, Ilah A, Ahmad IZ, Khan SA. Catharanthus roseus (L.) G. Don. An important drug: it\u2019s applications and production. Pharmacie Globale (IJCP). 2010;4(12):1\u201316.","journal-title":"Pharmacie Globale (IJCP)"},{"issue":"2","key":"2624_CR42","first-page":"631","volume":"3","author":"A Nisar","year":"2016","unstructured":"Nisar A, Mamat AS, Hatim MI, Aslam MS, Syarhabil M. An updated review on Catharanthus roseus: phytochemical and pharmacological analysis. Indian Res J Pharm Sci. 2016;3(2):631\u201353.","journal-title":"Indian Res J Pharm Sci"},{"issue":"2","key":"2624_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/ptr.2650060212","volume":"6","author":"FL Hsu","year":"1992","unstructured":"Hsu FL, Cheng JT. Investigation in rats of the antihyperglycemic effect of plant extracts used in taiwan for the treatment of diabetes mellitus. Phytother Res. 1992;6(2):108\u201311.","journal-title":"Phytother Res"},{"key":"2624_CR44","unstructured":"Nguywen VD. List of simple drugs and medicinal plants of value in Vietnam. In: Proc seminar of the use of medicinal plants in healthcare Tokyo: 1977; 1977. pp. 13\u201317."},{"issue":"1","key":"2624_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1568011023354452","volume":"2","author":"A Duflos","year":"2002","unstructured":"Duflos A, Kruczynski A, Barret J-M. Novel aspects of natural and modified vinca alkaloids. Curr Med Chem-Anti-Cancer Agents. 2002;2(1):55\u201370.","journal-title":"Curr Med Chem-Anti-Cancer Agents"},{"issue":"2","key":"2624_CR46","first-page":"431","volume":"4","author":"S Gajalakshmi","year":"2013","unstructured":"Gajalakshmi S, Vijayalakshmi S, Devi RV. Pharmacological activities of Catharanthus roseus: a perspective review. Int J Pharm Bio Sci. 2013;4(2):431\u20139.","journal-title":"Int J Pharm Bio Sci"},{"key":"2624_CR47","volume-title":"Happy accidents: serendipity in modern medical breakthroughs","author":"MA Meyers","year":"2007","unstructured":"Meyers MA. Happy accidents: serendipity in modern medical breakthroughs. New York: Arcade Publishing; 2007."},{"key":"2624_CR48","unstructured":"Farnsworth N. Plants and modern medicine: where science and folklore Meets. In: World Health Forum: 1985; 1985. pp. 76\u201380."},{"key":"2624_CR49","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5005\/jp\/books\/11166_21","volume-title":"Herbal medicine: a cancer chemopreventive and therapeutic perspective","author":"R Arora","year":"2010","unstructured":"Arora R, Malhotra P, Mathur AK, Mathur A, Govil C, Ahuja P. Anticancer alkaloids of Catharanthus roseus: transition from traditional to modern medicine. In: Arora R, editor. Herbal medicine: a cancer chemopreventive and therapeutic perspective. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd; 2010. p. 292\u2013310."},{"key":"2624_CR50","volume-title":"Cancer chemotherapeutic agents","author":"WO Foye","year":"1995","unstructured":"Foye WO. Cancer chemotherapeutic agents. Washington: Amer Chemical Society; 1995."},{"issue":"3","key":"2624_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2165\/00002512-199405030-00006","volume":"5","author":"KL Goa","year":"1994","unstructured":"Goa KL, Faulds D. Vinorelbine. Drugs Aging. 1994;5(3):200\u201334.","journal-title":"Drugs Aging"},{"issue":"6","key":"2624_CR52","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/1078-0432.CCR-07-2219","volume":"14","author":"J Bennouna","year":"2008","unstructured":"Bennouna J, Delord J-P, Campone M, Nguyen L. Vinflunine: a new microtubule inhibitor agent. Clin Cancer Res. 2008;14(6):1625\u201332.","journal-title":"Clin Cancer Res"},{"issue":"20","key":"2624_CR53","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.lfs.2003.03.005","volume":"74","author":"S Wang","year":"2004","unstructured":"Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, Dai R, Hu Z. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci. 2004;74(20):2467\u201378.","journal-title":"Life Sci"},{"issue":"2","key":"2624_CR54","first-page":"20","volume":"2","author":"JN Mishra","year":"2017","unstructured":"Mishra JN, Verma NK. A brief study on Catharanthus roseus: a review. Intern J Res Pharm Pharm Sci. 2017;2(2):20\u20133.","journal-title":"Intern J Res Pharm Pharm Sci"},{"key":"2624_CR55","unstructured":"Sayeed M, Jesmin MH, Sarker T, Rahman M, Alam M. Antitumor activity of leaf extracts of Catharanthus roseus (L.) G. Don. 2014."},{"issue":"3","key":"2624_CR56","first-page":"145","volume":"35","author":"R Chattopadhyay","year":"1991","unstructured":"Chattopadhyay R, Sarkar S, Ganguly S, Banerjee R, Basu T. Hypoglycemic and antihyperglycemic effect of leaves of Vinca rosea linn. Indian J Physiol Pharmacol. 1991;35(3):145\u201351.","journal-title":"Indian J Physiol Pharmacol"},{"issue":"3","key":"2624_CR57","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0378-8741(99)00095-1","volume":"67","author":"R Chattopadhyay","year":"1999","unstructured":"Chattopadhyay R. A comparative evaluation of some blood sugar lowering agents of plant origin. J Ethnopharmacol. 1999;67(3):367\u201372.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2624_CR58","first-page":"40","volume":"1","author":"PJ Patil","year":"2010","unstructured":"Patil PJ, Ghosh JS. Antimicrobial activity of Catharanthus roseus\u2014a detailed study. Br J Pharmacol Toxicol. 2010;1(1):40\u20134.","journal-title":"Br J Pharmacol Toxicol"},{"issue":"4","key":"2624_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.33786\/JCPR.2011.v01i04.007","volume":"1","author":"M Bhutkar","year":"2011","unstructured":"Bhutkar M, Bhise S. Studies on antioxidant properties of Catharanthus rosea and Catharanthus alba. J Curr Pharma Res. 2011;1(4):337.","journal-title":"J Curr Pharma Res"},{"issue":"3","key":"2624_CR60","first-page":"211","volume":"3","author":"S Agarwal","year":"2011","unstructured":"Agarwal S, Jacob S, Chettri N, Bisoyi S, Tazeen A, Vedamurthy A, Krishna V, Hoskeri H. Evaluation of in-vitro anthelminthic activity of Catharanthus roseus extract. Int J Pharm Sci Drug Res. 2011;3(3):211\u20133.","journal-title":"Int J Pharm Sci Drug Res"},{"issue":"5","key":"2624_CR61","first-page":"784","volume":"7","author":"MS Rajput","year":"2011","unstructured":"Rajput MS, Nair V, Chauhan A, Jawanjal H, Dange V. Evaluation of antidiarrheal activity of aerial parts of Vinca major in experimental animals. Middle-East J Sci Res. 2011;7(5):784\u20138.","journal-title":"Middle-East J Sci Res"},{"issue":"15","key":"2624_CR62","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.5897\/AJPP11.505","volume":"5","author":"KA Hassan","year":"2011","unstructured":"Hassan KA, Brenda AT, Patrick V, Patrick OE. In vivo antidiarrheal activity of the ethanolic leaf extract of Catharanthus roseus Linn. (Apocyanaceae) in Wistar rats. Afr J Pharm Pharmacol. 2011;5(15):1797\u2013800.","journal-title":"Afr J Pharm Pharmacol"},{"issue":"7\u20138","key":"2624_CR63","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.fitote.2007.06.008","volume":"78","author":"B Nayak","year":"2007","unstructured":"Nayak B, Anderson M, Pereira LP. Evaluation of wound-healing potential of Catharanthus roseus leaf extract in rats. Fitoterapia. 2007;78(7\u20138):540\u20134.","journal-title":"Fitoterapia"},{"issue":"8","key":"2624_CR64","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.3390\/molecules18089770","volume":"18","author":"SH Tiong","year":"2013","unstructured":"Tiong SH, Looi CY, Hazni H, Arya A, Paydar M, Wong WF, Cheah S-C, Mustafa MR, Awang K. Antidiabetic and antioxidant properties of alkaloids from Catharanthus roseus (L.) G. Don. Molecules. 2013;18(8):9770\u201384.","journal-title":"Molecules"},{"issue":"6","key":"2624_CR65","first-page":"927","volume":"68","author":"Y Patel","year":"2011","unstructured":"Patel Y, Vadgama V, Baxi S, Tripathi CB. Evaluation of hypolipidemic activity of leaf juice of Catharanthus roseus (Linn.) G. Donn. in guinea pigs. Acta Pol Pharm. 2011;68(6):927\u201335.","journal-title":"Acta Pol Pharm"},{"key":"2624_CR66","doi-asserted-by":"publisher","first-page":"8214821","DOI":"10.1155\/2022\/8214821","volume":"2022","author":"M Butnariu","year":"2022","unstructured":"Butnariu M, Quispe C, Herrera-Bravo J, Sharifi-Rad J, Singh L, Aborehab NM, Bouyahya A, Venditti A, Sen S, Acharya K, et al. The pharmacological activities of Crocus sativus L.: a review based on the mechanisms and therapeutic opportunities of its phytoconstituents. Oxid Med Cell Longev. 2022;2022:8214821.","journal-title":"Oxid Med Cell Longev"},{"issue":"7819","key":"2624_CR67","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-020-2546-8","volume":"584","author":"RS Nett","year":"2020","unstructured":"Nett RS, Lau W, Sattely ES. Discovery and engineering of colchicine alkaloid biosynthesis. Nature. 2020;584(7819):148\u201353.","journal-title":"Nature"},{"issue":"10","key":"2624_CR68","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1080\/13543776.2016.1214268","volume":"26","author":"A Mandhare","year":"2016","unstructured":"Mandhare A, Banerjee P. Therapeutic use of colchicine and its derivatives: a patent review. Expert Opin Ther Pat. 2016;26(10):1157\u201374.","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"2624_CR69","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/jat\/21.1.70","volume":"21","author":"P Kintz","year":"1997","unstructured":"Kintz P, Jamey C, Tracqui A, Mangin P. Colchicine poisoning: report of a fatal case and presentation of an HPLC procedure for body fluid and tissue analyses. J Anal Toxicol. 1997;21(1):70\u20132.","journal-title":"J Anal Toxicol"},{"issue":"6","key":"2624_CR70","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/00007691-200412000-00017","volume":"26","author":"JS Sussman","year":"2004","unstructured":"Sussman JS, Brozena SC, Skop N, Korecka M, Shaw LM. Accidental intravenous colchicine poisoning. Ther Drug Monit. 2004;26(6):688\u201392.","journal-title":"Ther Drug Monit"},{"key":"2624_CR71","doi-asserted-by":"crossref","unstructured":"Leung YY, Hui LLY, Kraus VB. Colchicine\u2014update on mechanisms of action and therapeutic uses. In: Seminars in arthritis and rheumatism. Elsevier; 2015. pp. 341\u201350.","DOI":"10.1016\/j.semarthrit.2015.06.013"},{"key":"2624_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","volume":"135","author":"PC Robinson","year":"2021","unstructured":"Robinson PC, Terkeltaub R, Pillinger MH, Shah B, Karalis V, Karatza E, Liew D, Imazio M, Cornel JH, Thompson PL. Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease. Am J Med. 2021;135:32\u20138.","journal-title":"Am J Med"},{"key":"2624_CR73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.athplu.2021.08.008","volume":"45","author":"F Roubille","year":"2021","unstructured":"Roubille F, Merlet N, Busseuil D, Ferron M, Shi Y, Mihalache-Avram T, Mecteau M, Brand G, Rivas D, Cossette M. Colchicine reduces atherosclerotic plaque vulnerability in rabbits. Atherosclerosis Plus. 2021;45:9.","journal-title":"Atherosclerosis Plus"},{"issue":"1","key":"2624_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc2427","volume":"8","author":"M Brvar","year":"2004","unstructured":"Brvar M, Ploj T, Kozelj G, Mozina M, Noc M, Bunc M. Case report: fatal poisoning with Colchicum autumnale. Crit Care. 2004;8(1):1\u20134.","journal-title":"Crit Care"},{"issue":"3","key":"2624_CR75","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1749-6632.1958.tb54906.x","volume":"76","author":"RL Noble","year":"1958","unstructured":"Noble RL, Beer C, Cutts J. Role of chance observations in chemotherapy: Vinca rosea. Ann N Y Acad Sci. 1958;76(3):882\u201394.","journal-title":"Ann N Y Acad Sci"},{"key":"2624_CR76","unstructured":"Arora RD, Menezes RG. Vinca alkaloid toxicity. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022."},{"issue":"1","key":"2624_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1568011023354290","volume":"2","author":"M Jordan","year":"2002","unstructured":"Jordan M. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem-Anti-Cancer Agents. 2002;2(1):1\u201317.","journal-title":"Curr Med Chem-Anti-Cancer Agents"},{"issue":"3","key":"2624_CR78","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2478\/aiht-2019-70-3258","volume":"70","author":"B Karahalil","year":"2019","unstructured":"Karahalil B, Yard\u0131m-Akaydin S, Nacak Baytas S. An overview of microtubule targeting agents for cancer therapy. Arh Hig Rada Toksikol. 2019;70(3):160\u201372.","journal-title":"Arh Hig Rada Toksikol"},{"issue":"6","key":"2624_CR79","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.21037\/tcr-20-682","volume":"9","author":"Z Cheng","year":"2020","unstructured":"Cheng Z, Lu X, Feng B. A review of research progress of antitumor drugs based on tubulin targets. Transl Cancer Res. 2020;9(6):4020\u20137.","journal-title":"Transl Cancer Res"},{"issue":"45","key":"2624_CR80","first-page":"10.5772","volume":"6","author":"J Kurek","year":"2018","unstructured":"Kurek J. Cytotoxic colchicine alkaloids: from plants to drugs. Cytotoxicity. 2018;6(45):10.5772.","journal-title":"Cytotoxicity"},{"issue":"12","key":"2624_CR81","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1158\/1535-7163.MCT-13-0401","volume":"12","author":"A Ganguly","year":"2013","unstructured":"Ganguly A, Yang H, Zhang H, Cabral F, Patel KD. Microtubule dynamics control tail retraction in migrating vascular endothelial cells. Mol Cancer Ther. 2013;12(12):2837\u201346.","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"2624_CR82","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1158\/0008-5472.CAN-13-1778","volume":"74","author":"MS Charpentier","year":"2014","unstructured":"Charpentier MS, Whipple RA, Vitolo MI, Boggs AE, Slovic J, Thompson KN, Bhandary L, Martin SS. Curcumin targets breast cancer stem\u2013like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res. 2014;74(4):1250\u201360.","journal-title":"Cancer Res"},{"issue":"11","key":"2624_CR83","first-page":"6269","volume":"37","author":"JH Cho","year":"2017","unstructured":"Cho JH, Joo YH, Shin EY, Park EJ, Kim MS. Anticancer effects of colchicine on hypopharyngeal cancer. Anticancer Res. 2017;37(11):6269\u201380.","journal-title":"Anticancer Res"},{"issue":"5","key":"2624_CR84","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.tiv.2012.01.024","volume":"26","author":"X-M Chen","year":"2012","unstructured":"Chen X-M, Liu J, Wang T, Shang J. Colchicine-induced apoptosis in human normal liver L-02 cells by mitochondrial mediated pathways. Toxicol In Vitro. 2012;26(5):649\u201355.","journal-title":"Toxicol In Vitro"},{"issue":"4","key":"2624_CR85","doi-asserted-by":"publisher","first-page":"5939","DOI":"10.3892\/mmr.2015.4222","volume":"12","author":"Z Huang","year":"2015","unstructured":"Huang Z, Xu Y, Peng W. Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways. Mol Med Rep. 2015;12(4):5939\u201344.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2624_CR86","doi-asserted-by":"publisher","first-page":"BSR20181802","DOI":"10.1042\/BSR20181802","volume":"39","author":"T Zhang","year":"2019","unstructured":"Zhang T, Chen W, Jiang X, Liu L, Wei K, Du H, Wang H, Li J. Anticancer effects and underlying mechanism of Colchicine on human gastric cancer cell lines in vitro and in vivo. Biosci Rep. 2019;39(1):BSR20181802.","journal-title":"Biosci Rep"},{"issue":"2","key":"2624_CR87","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.kjms.2015.12.006","volume":"32","author":"Z-Y Lin","year":"2016","unstructured":"Lin Z-Y, Kuo C-H, Wu D-C, Chuang W-L. Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines. Kaohsiung J Med Sci. 2016;32(2):68\u201373.","journal-title":"Kaohsiung J Med Sci"},{"issue":"20","key":"2624_CR88","doi-asserted-by":"publisher","first-page":"5674","DOI":"10.1039\/C5OB00406C","volume":"13","author":"B Singh","year":"2015","unstructured":"Singh B, Kumar A, Joshi P, Guru SK, Kumar S, Wani ZA, Mahajan G, Hussain A, Qazi AK, Kumar A. Colchicine derivatives with potent anticancer activity and reduced P-glycoprotein induction liability. Org Biomol Chem. 2015;13(20):5674\u201389.","journal-title":"Org Biomol Chem"},{"key":"2624_CR89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.5505\/TurkHijyen.2018.22755","volume":"75","author":"F Bakar-Ate\u015f","year":"2018","unstructured":"Bakar-Ate\u015f F, \u00d6zmen N, Kaya-Sezginer E, Kurt EE. Effects of colchicine on cell cycle arrest and MMP-2 mRNA expression in MCF-7 breast adenocarcinoma cells. Turk Hij Den Biyol Derg. 2018;75:239\u201344.","journal-title":"Turk Hij Den Biyol Derg"},{"issue":"11","key":"2624_CR90","first-page":"1231","volume":"4","author":"M Moudi","year":"2013","unstructured":"Moudi M, Go R, Yien CYS, Nazre M. Vinca alkaloids. Int J Prev Med. 2013;4(11):1231.","journal-title":"Int J Prev Med"},{"issue":"3","key":"2624_CR91","doi-asserted-by":"publisher","first-page":"147","DOI":"10.14499\/indonesianjpharm30iss3pp147","volume":"30","author":"ZM Taher","year":"2019","unstructured":"Taher ZM, Agouillal F, Marof AQ, Dailin DJ, Nurjayadi M, Razif EN, Gomaa SE, El Enshasy HA. Anticancer molecules from Catharanthus roseus. Indones J Pharm. 2019;30(3):147.","journal-title":"Indones J Pharm"},{"key":"2624_CR92","unstructured":"Allamsetty J, Pedada SP, Pedada N, Kolli D. A basic review on Vinca rosea. Int J Pharmacogn Chem. 2020:31\u201336."},{"issue":"10","key":"2624_CR93","first-page":"3899","volume":"2","author":"AM Retna","year":"2013","unstructured":"Retna AM, Ethalsa P. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Catharanthus roseus (Apocyanaceae). Int J Eng Res Technol. 2013;2(10):3899\u2013912.","journal-title":"Int J Eng Res Technol"},{"key":"2624_CR94","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.fitote.2015.01.019","volume":"102","author":"SH Tiong","year":"2015","unstructured":"Tiong SH, Looi CY, Arya A, Wong WF, Hazni H, Mustafa MR, Awang K. Vindogentianine, a hypoglycemic alkaloid from Catharanthus roseus (L.) G. Don (Apocynaceae). Fitoterapia. 2015;102:182\u20138.","journal-title":"Fitoterapia"},{"issue":"2","key":"2624_CR95","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.3390\/molecules20022973","volume":"20","author":"L Almagro","year":"2015","unstructured":"Almagro L, Fern\u00e1ndez-P\u00e9rez F, Pedre\u00f1o MA. Indole alkaloids from Catharanthus roseus: bioproduction and their effect on human health. Molecules. 2015;20(2):2973\u20133000.","journal-title":"Molecules"},{"issue":"17","key":"2624_CR96","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.bmcl.2018.06.044","volume":"28","author":"E Martino","year":"2018","unstructured":"Martino E, Casamassima G, Castiglione S, Cellupica E, Pantalone S, Papagni F, Rui M, Siciliano AM, Collina S. Vinca alkaloids and analogues as anti-cancer agents: looking back, peering ahead. Bioorg Med Chem Lett. 2018;28(17):2816\u201326.","journal-title":"Bioorg Med Chem Lett"},{"issue":"47","key":"2624_CR97","doi-asserted-by":"publisher","first-page":"e13228","DOI":"10.1097\/MD.0000000000013228","volume":"97","author":"B Pernot","year":"2018","unstructured":"Pernot B, Gyan E, Maillot F, Hodges P, Ertault M, Ferreira-Maldent N. Lymphomas diagnosed in an internal medicine department compared to lymphomas diagnosed in other departments: clinical and outcome differences. Medicine. 2018;97(47):e13228.","journal-title":"Medicine"},{"issue":"5","key":"2624_CR98","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1089\/jayao.2018.0041","volume":"7","author":"GJ Schiller","year":"2018","unstructured":"Schiller GJ, Damon LE, Coutre SE, Hsu P, Bhat G, Douer D. High-dose vincristine sulfate liposome injection, for advanced, relapsed, or refractory philadelphia chromosome-negative acute lymphoblastic leukemia in an adolescent and young adult subgroup of a phase 2 clinical trial. J Adolesc Young Adult Oncol. 2018;7(5):546\u201352.","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"13","key":"2624_CR99","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.tetlet.2012.01.060","volume":"53","author":"L Wang","year":"2012","unstructured":"Wang L, He H-P, Di Y-T, Zhang Y, Hao X-J. Catharoseumine, a new monoterpenoid indole alkaloid possessing a peroxy bridge from Catharanthus roseus. Tetrahedron Lett. 2012;53(13):1576\u20138.","journal-title":"Tetrahedron Lett"},{"issue":"8","key":"2624_CR100","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1158\/1535-7163.MCT-09-0366","volume":"8","author":"EA Perez","year":"2009","unstructured":"Perez EA. Microtubule inhibitors: differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol Cancer Ther. 2009;8(8):2086\u201395.","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"2624_CR101","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.bcp.2010.12.026","volume":"81","author":"S Sertel","year":"2011","unstructured":"Sertel S, Fu Y, Zu Y, Rebacz B, Konkimalla B, Plinkert PK, Kr\u00e4mer A, Gertsch J, Efferth T. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine. Biochem Pharmacol. 2011;81(6):723\u201335.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2624_CR102","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11101-013-9302-8","volume":"13","author":"P Barbier","year":"2014","unstructured":"Barbier P, Tsvetkov PO, Breuzard G, Devred F. Deciphering the molecular mechanisms of anti-tubulin plant derived drugs. Phytochem Rev. 2014;13(1):157\u201369.","journal-title":"Phytochem Rev"},{"key":"2624_CR103","unstructured":"Wang L, Liu X, Kreis W, Budman D. Activation of MAP kinase during apoptosis mediated by vinorelbine in MCF-7 cells. In: Proc Am Assoc Cancer Res; 1999. p. 13."},{"issue":"3","key":"2624_CR104","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1242\/jcs.102.3.401","volume":"102","author":"MA Jordan","year":"1992","unstructured":"Jordan MA, Thrower D, Wilson L. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci. 1992;102(3):401\u201316.","journal-title":"J Cell Sci"},{"issue":"5","key":"2624_CR105","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1021\/bi00056a013","volume":"32","author":"RJ Toso","year":"1993","unstructured":"Toso RJ, Jordan MA, Farrell KW, Matsumoto B, Wilson L. Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine. Biochemistry. 1993;32(5):1285\u201393.","journal-title":"Biochemistry"},{"key":"2624_CR106","first-page":"40","volume":"1","author":"R Vishwakarma","year":"2019","unstructured":"Vishwakarma R, Prajapati V. Drug of vinca: used as a anticancer agent. Int J Curr Res. 2019;1:40\u20134.","journal-title":"Int J Curr Res"},{"key":"2624_CR107","first-page":"23","volume":"6","author":"A Kumar","year":"2016","unstructured":"Kumar A. Vincristine and vinblastine: a review. IJMPS. 2016;6:23\u201330.","journal-title":"IJMPS"},{"issue":"2","key":"2624_CR108","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/bcp.13126","volume":"83","author":"D Bates","year":"2017","unstructured":"Bates D, Eastman A. Microtubule destabilising agents: far more than just antimitotic anticancer drugs. Br J Clin Pharmacol. 2017;83(2):255\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"8 Part 1","key":"2624_CR109","first-page":"1390","volume":"23","author":"IS Johnson","year":"1963","unstructured":"Johnson IS, Armstrong JG, Gorman M, Burnett JP. The vinca alkaloids: a new class of oncolytic agents. Cancer Res. 1963;23(8 Part 1):1390\u2013427.","journal-title":"Cancer Res"},{"key":"2624_CR110","unstructured":"Beck WT, Cass CE, Houghton PJ. Microtubule-targeting anticancer drugs derived from plants and microbes: vinca alkaloids, taxanes, and epothilones. In: Holland-Frei cancer medicine. 5th ed. BC Decker; 2000."},{"issue":"3","key":"2624_CR111","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1021\/np800568j","volume":"72","author":"DGI Kingston","year":"2009","unstructured":"Kingston DGI. Tubulin-interactive natural products as anticancer agents. J Nat Prod. 2009;72(3):507\u201315.","journal-title":"J Nat Prod"},{"issue":"6","key":"2624_CR112","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0305-7372(95)90015-2","volume":"21","author":"S Joel","year":"1995","unstructured":"Joel S. The comparative clinical pharmacology of vincristine and vindesine: does vindesine offer any advantage in clinical use? Cancer Treat Rev. 1995;21(6):513\u201325.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"2624_CR113","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1054\/bjoc.2000.1203","volume":"82","author":"R Gregory","year":"2000","unstructured":"Gregory R, Smith I. Vinorelbine\u2013a clinical review. Br J Cancer. 2000;82(12):1907\u201313.","journal-title":"Br J Cancer"},{"issue":"10","key":"2624_CR114","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1073\/pnas.92.10.4507","volume":"92","author":"S Haldar","year":"1995","unstructured":"Haldar S, Jena N, Croce CM. Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci. 1995;92(10):4507\u201311.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"2624_CR115","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/1120009X.2018.1487149","volume":"30","author":"MA Altinoz","year":"2018","unstructured":"Altinoz MA, Ozpinar A, Alturfan EE, Elmaci I. Vinorelbine\u2019s anti-tumor actions may depend on the mitotic apoptosis, autophagy and inflammation: hypotheses with implications for chemo-immunotherapy of advanced cancers and pediatric gliomas. J Chemother. 2018;30(4):203\u201312.","journal-title":"J Chemother"},{"issue":"5","key":"2624_CR116","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.3390\/molecules17055893","volume":"17","author":"P Keglevich","year":"2012","unstructured":"Keglevich P, Hazai L, Kalaus G, Sz\u00e1ntay C. Modifications on the basic skeletons of vinblastine and vincristine. Molecules. 2012;17(5):5893\u2013914.","journal-title":"Molecules"},{"issue":"15","key":"2624_CR117","doi-asserted-by":"publisher","first-page":"5061","DOI":"10.1016\/j.bmc.2007.05.045","volume":"15","author":"Y Shao","year":"2007","unstructured":"Shao Y, Ding H, Tang W, Lou L, Hu L. Synthesis and structure\u2013activity relationships study of novel anti-tumor carbamate anhydrovinblastine analogues. Bioorg Med Chem. 2007;15(15):5061\u201375.","journal-title":"Bioorg Med Chem."},{"issue":"4","key":"2624_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00003495-199200444-00002","volume":"44","author":"X-J Zhou","year":"1992","unstructured":"Zhou X-J, Rahmani R. Preclinical and clinical pharmacology of vinca alkaloids. Drugs. 1992;44(4):1\u201316.","journal-title":"Drugs"},{"issue":"7","key":"2624_CR119","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0091270006288953","volume":"46","author":"AY Bedikian","year":"2006","unstructured":"Bedikian AY, Vardeleon A, Smith T, Campbell S, Namdari R. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients. J Clin Pharmacol. 2006;46(7):727\u201337.","journal-title":"J Clin Pharmacol"},{"key":"2624_CR120","doi-asserted-by":"publisher","first-page":"38","DOI":"10.33545\/27072827.2020.v1.i2a.17","volume":"1","author":"D Tiwari","year":"2020","unstructured":"Tiwari D, Tiwari M. Vincristine: Beyond on anticancer treatment. Int J Pharmacogn Life Sci. 2020;1:38\u201343.","journal-title":"Int J Pharmacogn Life Sci."},{"key":"2624_CR121","first-page":"270","volume":"47","author":"K Bairy","year":"2003","unstructured":"Bairy K, Sanath S, Jagetia G, Somayaji S, Vidyasagar M, Baliga M. Evaluation of intraperitoneal vincristine in malignant peritoneal effusion. Indian J Physiol Pharmacol. 2003;47:270\u20138.","journal-title":"Indian J Physiol Pharmacol"},{"issue":"5","key":"2624_CR122","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1158\/0008-5472.CAN-06-3520","volume":"67","author":"L Groth-Pedersen","year":"2007","unstructured":"Groth-Pedersen L, Ostenfeld MS, H\u00f8yer-Hansen M, Nylandsted J, J\u00e4\u00e4ttel\u00e4 M. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Can Res. 2007;67(5):2217\u201325.","journal-title":"Can Res"},{"issue":"1","key":"2624_CR123","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3892\/ijmm.2012.1167","volume":"31","author":"Y Tu","year":"2013","unstructured":"Tu Y, Cheng S, Zhang S, Sun H, Xu Z. Vincristine induces cell cycle arrest and apoptosis in SH-SY5Y human neuroblastoma cells. Int J Mol Med. 2013;31(1):113\u20139.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2624_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-015-0176-7","volume":"8","author":"M-W Chao","year":"2015","unstructured":"Chao M-W, Lai M-J, Liou J-P, Chang Y-L, Wang J-C, Pan S-L, Teng C-M. The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo. J Hematol Oncol. 2015;8(1):1\u201315.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"2624_CR125","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/oxfordjournals.annonc.a057748","volume":"1","author":"D Nielsen","year":"1990","unstructured":"Nielsen D, Dombernowsky P, Skovsgaard T, Jensen J, Andersen E, Engelholm S, Hansen M. Epirubicin or epirubicin and vindesine in advanced breast cancer. A phase III study. Ann Oncol. 1990;1(4):275\u201380.","journal-title":"Ann Oncol"},{"key":"2624_CR126","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0305-7372(80)80011-9","volume":"7","author":"I Smith","year":"1980","unstructured":"Smith I, Hedley D, Coombes R, Powles T. A comparison of combination chemotherapy using vindesine or vincristine with adriamycin in the treatment of advanced breast carcinoma. Cancer Treat Rev. 1980;7:71\u20133.","journal-title":"Cancer Treat Rev"},{"issue":"12","key":"2624_CR127","first-page":"1119","volume":"67","author":"J Jewkes","year":"1983","unstructured":"Jewkes J, Harper P, Tobias J, Geddes D, Souhami R, Spiro S. Comparison of vincristine and vindesine in the treatment of inoperable non-small cell bronchial carcinoma. Cancer Treat Rep. 1983;67(12):1119\u201321.","journal-title":"Cancer Treat Rep"},{"issue":"2","key":"2624_CR128","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11060-014-1652-6","volume":"121","author":"AM Cappellano","year":"2015","unstructured":"Cappellano AM, Petrilli AS, Da Silva NS, Silva FA, Paiva PM, Cavalheiro S, Bouffet E. Single agent vinorelbine in pediatric patients with progressive optic pathway glioma. J Neurooncol. 2015;121(2):405\u201312.","journal-title":"J Neurooncol"},{"key":"2624_CR129","doi-asserted-by":"crossref","unstructured":"Tuna S, Altinoz MA, Karasu A, Canbolat A, Bilir A. Selective COX-2 inhibitor (Rofecoxib) inhibits vinorelbine cytotoxicity in C6 glioma cells in vitro. Open Pathol J. 2009;3(1).","DOI":"10.2174\/1874375700903010022"},{"issue":"2","key":"2624_CR130","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s13277-010-0131-8","volume":"32","author":"Y Shi","year":"2011","unstructured":"Shi Y, Chen L, Li J, Lv Y-L, Sun Q, Wang L-X, Jiao S-C. Prognostic and predictive values of pERK1\/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy. Tumor Biol. 2011;32(2):381\u201390.","journal-title":"Tumor Biol."},{"issue":"2","key":"2624_CR131","first-page":"51","volume":"1","author":"A Ameri","year":"2013","unstructured":"Ameri A, Shahrad B, Fazlalizadeh A, Madani H, Mousavizadeh A, Moghadam S. Vinorelbine and docetaxel combination as the first line treatment in patients with metastatic breast cancer: results of a multi-centric phase ii trial in Iran. Rep Radiother Oncol. 2013;1(2):51\u20137.","journal-title":"Rep Radiother Oncol"},{"issue":"1","key":"2624_CR132","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3109\/13880200903046187","volume":"48","author":"M Khanavi","year":"2010","unstructured":"Khanavi M, Pourmoslemi S, Farahanikia B, Hadjiakhoondi A, Ostad SN. Cytotoxicity of Vinca minor. Pharm Biol. 2010;48(1):96\u2013100.","journal-title":"Pharm Biol"},{"issue":"1","key":"2624_CR133","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI13275","volume":"110","author":"AL Blajeski","year":"2002","unstructured":"Blajeski AL, Phan VA, Kottke TJ, Kaufmann SH. G 1 and G 2 cell-cycle arrest following microtubule depolymerization in human breast cancer cells. J Clin Investig. 2002;110(1):91\u20139.","journal-title":"J Clin Investig"},{"key":"2624_CR134","doi-asserted-by":"publisher","first-page":"104626","DOI":"10.1016\/j.bioorg.2021.104626","volume":"107","author":"S Al-Rashed","year":"2021","unstructured":"Al-Rashed S, Baker A, Ahmad SS, Syed A, Bahkali AH, Elgorban AM, Khan MS. Vincamine, a safe natural alkaloid, represents a novel anticancer agent. Bioorg Chem. 2021;107:104626.","journal-title":"Bioorg Chem"},{"issue":"2\u20133","key":"2624_CR135","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0300-9084(02)01369-X","volume":"84","author":"C Fleury","year":"2002","unstructured":"Fleury C, Mignotte B, Vayssi\u00e8re J-L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 2002;84(2\u20133):131\u201341.","journal-title":"Biochimie"},{"issue":"3","key":"2624_CR136","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","volume":"10","author":"G Nuki","year":"2008","unstructured":"Nuki G. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep. 2008;10(3):218\u201327.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"2624_CR137","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.fct.2009.03.012","volume":"47","author":"DM Pereira","year":"2009","unstructured":"Pereira DM, Ferreres F, Oliveira J, Valent\u00e3o P, Andrade PB, Sottomayor M. Targeted metabolite analysis of Catharanthus roseus and its biological potential. Food Chem Toxicol. 2009;47(6):1349\u201354.","journal-title":"Food Chem Toxicol"},{"issue":"8\u20139","key":"2624_CR138","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.phymed.2009.10.008","volume":"17","author":"DM Pereira","year":"2010","unstructured":"Pereira DM, Ferreres F, Oliveira JM, Gaspar L, Faria J, Valent\u00e3o P, Sottomayor M, Andrade PB. Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission. Phytomedicine. 2010;17(8\u20139):646\u201352.","journal-title":"Phytomedicine"},{"key":"2624_CR139","doi-asserted-by":"publisher","first-page":"8615242","DOI":"10.1155\/2022\/8615242","volume":"2022","author":"MM Quetglas-Llabr\u00e9s","year":"2022","unstructured":"Quetglas-Llabr\u00e9s MM, Quispe C, Herrera-Bravo J, Catarino MD, Pereira OR, Cardoso SM, Dua K, Chellappan DK, Pabreja K, Satija S, et al. Pharmacological properties of bergapten: mechanistic and therapeutic aspects. Oxid Med Cell Longev. 2022;2022:8615242.","journal-title":"Oxid Med Cell Longev"},{"key":"2624_CR140","doi-asserted-by":"publisher","first-page":"4024331","DOI":"10.1155\/2022\/4024331","volume":"2022","author":"Y Taheri","year":"2022","unstructured":"Taheri Y, Quispe C, Herrera-Bravo J, Sharifi-Rad J, Ezzat SM, Merghany RM, Shaheen S, Azmi L, Prakash Mishra A, Sener B, et al. Urtica dioica-derived phytochemicals for pharmacological and therapeutic applications. Evid Based Complement Altern Med. 2022;2022:4024331.","journal-title":"Evid Based Complement Altern Med"},{"issue":"10","key":"2624_CR141","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/molecules24101854","volume":"24","author":"B Salehi","year":"2019","unstructured":"Salehi B, Capanoglu E, Adrar N, Catalkaya G, Shaheen S, Jaffer M, Giri L, Suyal R, Jugran AK, Calina D, et al. Cucurbits plants: a key emphasis to its pharmacological potential. Molecules. 2019;24(10):23.","journal-title":"Molecules"},{"key":"2624_CR142","doi-asserted-by":"publisher","first-page":"592654","DOI":"10.3389\/fphar.2020.592654","volume":"11","author":"B Salehi","year":"2021","unstructured":"Salehi B, Quispe C, Chamkhi I, El Omari N, Balahbib A, Sharifi-Rad J, Bouyahya A, Akram M, Iqbal M, Docea AO, et al. Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence. Front Pharmacol. 2021;11:592654.","journal-title":"Front Pharmacol"},{"issue":"3","key":"2624_CR143","first-page":"683","volume":"53","author":"AO Docea","year":"2012","unstructured":"Docea AO, Mitrut P, Grigore D, Pirici D, Calina DC, Gofita E. Immunohistochemical expression of TGF beta (TGF-beta), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas. Rom J Morphol Embryol. 2012;53(3):683\u201392.","journal-title":"Rom J Morphol Embryol"},{"issue":"1","key":"2624_CR144","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10585-019-09990-1","volume":"37","author":"S Sutoo","year":"2020","unstructured":"Sutoo S, Maeda T, Suzuki A, Kato Y. Adaptation to chronic acidic extracellular pH elicits a sustained increase in lung cancer cell invasion and metastasis. Clin Exp Metastasis. 2020;37(1):133\u201344.","journal-title":"Clin Exp Metastasis"},{"key":"2624_CR145","doi-asserted-by":"publisher","first-page":"664197","DOI":"10.3389\/fnut.2021.664197","volume":"8","author":"J Sharifi-Rad","year":"2021","unstructured":"Sharifi-Rad J, Bahukhandi A, Dhyani P, Sati P, Capanoglu E, Docea AO, Al-Harrasi A, Dey A, Calina D. Therapeutic potential of neoechinulins and their derivatives: an overview of the molecular mechanisms behind pharmacological activities. Front Nutr. 2021;8:664197.","journal-title":"Front Nutr"},{"issue":"3","key":"2624_CR146","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/ptr.6884","volume":"35","author":"B Salehi","year":"2021","unstructured":"Salehi B, Prakash Mishra A, Nigam M, Karazhan N, Shukla I, Kie\u0142tyka-Dadasiewicz A, Sawicka B, G\u0142owacka A, Abu-Darwish MS, Hussein Tarawneh A, et al. Ficus plants: state of the art from a phytochemical, pharmacological, and toxicological perspective. Phytother Res. 2021;35(3):1187\u2013217.","journal-title":"Phytother Res"},{"issue":"7","key":"2624_CR147","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/kjm2.12374","volume":"37","author":"Z-Y Lin","year":"2021","unstructured":"Lin Z-Y, Yeh M-L, Huang C-I, Chen S-C, Huang C-F, Huang J-F, Dai C-Y, Yu M-L, Chuang W-L. Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinoma. Kaohsiung J Med Sci. 2021;37(7):616\u201323.","journal-title":"Kaohsiung J Med Sci"},{"issue":"4","key":"2624_CR148","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1021\/mp400760b","volume":"11","author":"JH Gill","year":"2014","unstructured":"Gill JH, Loadman PM, Shnyder SD, Cooper P, Atkinson JM, Ribeiro Morais G, Patterson LH, Falconer RA. Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity. Mol Pharm. 2014;11(4):1294\u2013300.","journal-title":"Mol Pharm"},{"key":"2624_CR149","doi-asserted-by":"publisher","first-page":"113530","DOI":"10.1016\/j.ab.2019.113530","volume":"593","author":"R Parthasarathy","year":"2020","unstructured":"Parthasarathy R, Shanmuganathan R, Pugazhendhi A. Vinblastine production by the endophytic fungus Curvularia verruculosa from the leaves of Catharanthus roseus and its in vitro cytotoxicity against HeLa cell line. Anal Biochem. 2020;593:113530.","journal-title":"Anal Biochem"},{"issue":"9","key":"2624_CR150","first-page":"849","volume":"10","author":"J \u0160kubn\u00edk","year":"2021","unstructured":"\u0160kubn\u00edk J, Pavl\u00ed\u010dkov\u00e1 VS, Ruml T, Rimpelov\u00e1 S. Vincristine in combination therapy of cancer: emerging trends in clinics. Biology (Basel). 2021;10(9):849.","journal-title":"Biology (Basel)"},{"issue":"3","key":"2624_CR151","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00280-012-2042-4","volume":"71","author":"JA Silverman","year":"2013","unstructured":"Silverman JA, Deitcher SR. Marqibo\u00ae (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemother Pharmacol. 2013;71(3):555\u201364.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2624_CR152","doi-asserted-by":"publisher","first-page":"114647","DOI":"10.1016\/j.jep.2021.114647","volume":"284","author":"S Kumar","year":"2022","unstructured":"Kumar S, Singh B, Singh R. Catharanthus roseus (L.) G. Don: a review of its ethnobotany, phytochemistry, ethnopharmacology and toxicities. J Ethnopharmacol. 2022;284:114647.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"2624_CR153","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1515\/bjmg-2016-0002","volume":"19","author":"NM Mhaidat","year":"2016","unstructured":"Mhaidat NM, Alzoubi KH, Khabour OF, Alawneh KZ, Raffee LA, Alsatari ES, Hussein EI, Bani-Hani KE. Assessment of genotoxicity of vincristine, vinblastine and vinorelbine in human cultured lymphocytes: a comparative study. Balkan J Med Genet. 2016;19(1):13\u201320.","journal-title":"Balkan J Med Genet"},{"issue":"10","key":"2624_CR154","doi-asserted-by":"publisher","first-page":"Fso750","DOI":"10.2144\/fsoa-2020-0095","volume":"7","author":"MR Valerio","year":"2021","unstructured":"Valerio MR, Spadaro P, Arcan\u00e0 C, Borsellino N, Cipolla C, Vigneri P, Piazza D, Gebbia V. Oral vinorelbine and capecitabine as first-line therapy in metastatic breast cancer: a retrospective analysis. Future Sci OA. 2021;7(10):Fso750.","journal-title":"Future Sci OA"},{"key":"2624_CR155","doi-asserted-by":"publisher","first-page":"485042","DOI":"10.1155\/2012\/485042","volume":"2012","author":"J-J Lu","year":"2012","unstructured":"Lu J-J, Bao J-L, Chen X-P, Huang M, Wang Y-T. Alkaloids isolated from natural herbs as the anticancer agents. Evid-Based Complement Altern Med. 2012;2012:485042.","journal-title":"Evid-Based Complement Altern Med"},{"issue":"12","key":"2624_CR156","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.3390\/molecules24122317","volume":"24","author":"K Wada","year":"2019","unstructured":"Wada K, Yamashita H. Cytotoxic effects of diterpenoid alkaloids against human cancer cells. Molecules. 2019;24(12):2317.","journal-title":"Molecules"},{"issue":"7","key":"2624_CR157","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/2472555218777968","volume":"23","author":"KK Javarappa","year":"2018","unstructured":"Javarappa KK, Tsallos D, Heckman CA. A multiplexed screening assay to evaluate chemotherapy-induced myelosuppression using healthy peripheral blood and bone marrow. SLAS Discov. 2018;23(7):687\u201396.","journal-title":"SLAS Discov"},{"issue":"6","key":"2624_CR158","doi-asserted-by":"publisher","first-page":"9784","DOI":"10.1021\/acsomega.9b00652","volume":"4","author":"CM Chagas","year":"2019","unstructured":"Chagas CM, Alisaraie L. Metabolites of vinca alkaloid vinblastine: tubulin binding and activation of nausea-associated receptors. ACS Omega. 2019;4(6):9784\u201399.","journal-title":"ACS Omega"},{"issue":"1","key":"2624_CR159","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5306\/wjco.v7.i1.87","volume":"7","author":"FY Kreidieh","year":"2016","unstructured":"Kreidieh FY, Moukadem HA, El Saghir NS. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol. 2016;7(1):87\u201397.","journal-title":"World J Clin Oncol"},{"issue":"12","key":"2624_CR160","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/ijd.13906","volume":"57","author":"B Rubio-Gonzalez","year":"2018","unstructured":"Rubio-Gonzalez B, Juh\u00e1sz M, Fortman J, Mesinkovska NA. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. Int J Dermatol. 2018;57(12):1417\u201324.","journal-title":"Int J Dermatol"},{"key":"2624_CR161","doi-asserted-by":"publisher","first-page":"750507","DOI":"10.3389\/fphar.2022.750507","volume":"13","author":"H Was","year":"2022","unstructured":"Was H, Borkowska A, Bagues A, Tu L, Liu JYH, Lu Z, Rudd JA, Nurgali K, Abalo R. Mechanisms of chemotherapy-induced neurotoxicity. Front Pharmacol. 2022;13:750507.","journal-title":"Front Pharmacol"},{"issue":"8","key":"2624_CR162","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/cells11081326","volume":"11","author":"AW Khan","year":"2022","unstructured":"Khan AW, Farooq M, Haseeb M, Choi S. Role of plant-derived active constituents in cancer treatment and their mechanisms of action. Cells. 2022;11(8):1325.","journal-title":"Cells"},{"issue":"4","key":"2624_CR163","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1055\/s-0041-1731581","volume":"10","author":"T Tvsvgk","year":"2021","unstructured":"Tvsvgk T, Handa A, Kumar K, Mutreja D, Subramanian S. Chemotherapy-associated pulmonary toxicity-case series from a single center. South Asian J Cancer. 2021;10(4):255\u201360.","journal-title":"South Asian J Cancer"},{"issue":"2","key":"2624_CR164","doi-asserted-by":"publisher","first-page":"130","DOI":"10.5492\/wjccm.v4.i2.130","volume":"4","author":"AE Mirrakhimov","year":"2015","unstructured":"Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: a clinical review. World J Crit Care Med. 2015;4(2):130\u20138.","journal-title":"World J Crit Care Med"},{"key":"2624_CR165","doi-asserted-by":"publisher","first-page":"3028387","DOI":"10.1155\/2020\/3028387","volume":"2020","author":"AM Alzahrani","year":"2020","unstructured":"Alzahrani AM, Rajendran P. The multifarious link between cytochrome P450s and cancer. Oxid Med Cell Longev. 2020;2020:3028387.","journal-title":"Oxid Med Cell Longev"},{"issue":"14","key":"2624_CR166","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.2174\/0929867324666170502123639","volume":"25","author":"A Haque","year":"2018","unstructured":"Haque A, Rahman MA, Faizi MSH, Khan MS. Next generation antineoplastic agents: a review on structurally modified vinblastine (VBL) analogues. Curr Med Chem. 2018;25(14):1650\u201362.","journal-title":"Curr Med Chem"},{"issue":"4","key":"2624_CR167","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms21041233","volume":"21","author":"AO Docea","year":"2020","unstructured":"Docea AO, Calina D, Buga AM, Zlatian O, Paoliello MMB, Mogosanu GD, Streba CT, Popescu EL, Stoica AE, Birca AC, et al. The effect of silver nanoparticles on antioxidant\/pro-oxidant balance in a murine model. Int J Mol Sci. 2020;21(4):17.","journal-title":"Int J Mol Sci"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-022-02624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-022-02624-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-022-02624-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T10:24:44Z","timestamp":1700648684000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-022-02624-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2624"],"URL":"https:\/\/doi.org\/10.1186\/s12935-022-02624-9","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"assertion":[{"value":"6 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}